C. Villasante

1.5k total citations
50 papers, 1.1k citations indexed

About

C. Villasante is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, C. Villasante has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 22 papers in Physiology and 6 papers in Surgery. Recurrent topics in C. Villasante's work include Asthma and respiratory diseases (14 papers), Respiratory Support and Mechanisms (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). C. Villasante is often cited by papers focused on Asthma and respiratory diseases (14 papers), Respiratory Support and Mechanisms (13 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). C. Villasante collaborates with scholars based in Spain, United Kingdom and United States. C. Villasante's co-authors include José Luís Viejo, Marc Miravitlles, Juan F. Masa, V. Sobradillo, L. Fernández-Fau, Carlos A. Jiménez-Ruíz, Rafael Gabriel, Montse Ferrer, Jordi Alonso and Gemma Vilagut and has published in prestigious journals such as European Respiratory Journal, Thorax and Allergy.

In The Last Decade

C. Villasante

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Villasante Spain 15 912 621 96 93 73 50 1.1k
Hein Brackel Netherlands 20 691 0.8× 555 0.9× 70 0.7× 59 0.6× 80 1.1× 36 1.0k
Nemr Eid United States 18 872 1.0× 661 1.1× 66 0.7× 64 0.7× 56 0.8× 72 1.3k
Anne Hildur Henriksen Norway 20 615 0.7× 489 0.8× 102 1.1× 113 1.2× 67 0.9× 44 964
Wendy Fergusson New Zealand 18 1.2k 1.3× 527 0.8× 170 1.8× 111 1.2× 52 0.7× 22 1.4k
Mathew Williams New Zealand 17 1.4k 1.5× 1.2k 2.0× 58 0.6× 54 0.6× 60 0.8× 35 1.7k
Filippo Catalano Italy 20 1.0k 1.1× 690 1.1× 76 0.8× 85 0.9× 53 0.7× 55 1.5k
DS Postma Netherlands 13 945 1.0× 654 1.1× 43 0.4× 73 0.8× 44 0.6× 18 1.1k
Fernando De Benedetto Italy 15 883 1.0× 704 1.1× 84 0.9× 65 0.7× 38 0.5× 48 1.2k
Carlos Villasante Spain 13 1.1k 1.2× 829 1.3× 98 1.0× 99 1.1× 99 1.4× 28 1.5k
Rodrigo Abensur Athanazio Brazil 18 610 0.7× 202 0.3× 129 1.3× 67 0.7× 66 0.9× 74 1.0k

Countries citing papers authored by C. Villasante

Since Specialization
Citations

This map shows the geographic impact of C. Villasante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Villasante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Villasante more than expected).

Fields of papers citing papers by C. Villasante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Villasante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Villasante. The network helps show where C. Villasante may publish in the future.

Co-authorship network of co-authors of C. Villasante

This figure shows the co-authorship network connecting the top 25 collaborators of C. Villasante. A scholar is included among the top collaborators of C. Villasante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Villasante. C. Villasante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamarrón, Ester, David Romero, C. Villasante, et al.. (2020). Should we consider paranasal and chest computed tomography in severe asthma patients?. Respiratory Medicine. 169. 106013–106013. 4 indexed citations
2.
García‐Río, Francisco, et al.. (2010). Bronchial reactivity indices are determinants of health-related quality of life in patients with stable asthma. Thorax. 65(9). 795–800. 11 indexed citations
3.
Soriano, Joan B., Julio Ancochea, Marc Miravitlles, et al.. (2009). Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. European Respiratory Journal. 36(4). 758–765. 124 indexed citations
4.
Mediano, Olga, Francisco García‐Río, & C. Villasante. (2006). Comparison of Carbon Dioxide Rebreathing During Application of Continuous Positive Airway Pressure With 3 Types of Nasal Mask. Archivos de Bronconeumología. 42(4). 189–193. 2 indexed citations
5.
García‐Río, Francisco, Manuel Ramı́rez, Olga Mediano, et al.. (2006). Exhaled Nitric Oxide and Airway Caliber during Exercise-Induced Bronchoconstriction. International Journal of Sports Medicine. 27(11). 905–910. 6 indexed citations
6.
Lindgren, Björn, Malcolm R. Sears, Mhairi Campbell, et al.. (2005). Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain. International Journal of Clinical Practice. 59(1). 62–68. 8 indexed citations
7.
Pauwels, Ruben, M.R. Sears, Mhairi Campbell, et al.. (2003). Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. European Respiratory Journal. 22(5). 787–794. 99 indexed citations
8.
Ferrer, Montse, C. Villasante, Jordi Alonso, et al.. (2002). Interpretation of quality of life scores from the St George's Respiratory Questionnaire. European Respiratory Journal. 19(3). 405–413. 241 indexed citations
9.
Ind, P.W., et al.. (2002). Safety of formoterol by Turbuhaler® as reliever medication compared with terbutaline in moderate asthma. European Respiratory Journal. 20(4). 859–866. 40 indexed citations
10.
Jiménez-Ruíz, Carlos A., V. Sobradillo, Rafael Gabriel, et al.. (2002). Síntomas respiratorios y diagnóstico de EPOC en fumadores de distintas labores de tabaco. Resultados del estudio IBERPOC. Archivos de Bronconeumología. 38(11). 530–535. 9 indexed citations
11.
García‐Río, Francisco, Jesús Pino, Teresa Ramírez, et al.. (2002). Inspiratory neural drive response to hypoxia adequately estimates peripheral chemosensitivity in OSAHS patients. European Respiratory Journal. 20(3). 724–732. 22 indexed citations
12.
Perpiñá, M., V. Sobradillo, F. Manresa, et al.. (2000). Consistencia interna y validez de contenido de la versión española del Asthma Autonomy Questionnaire. Archivos de Bronconeumología. 36(2). 90–94. 4 indexed citations
13.
Perpiñá, M., et al.. (1999). Búsqueda de información y toma de decisiones en pacientes asmáticos. Archivos de Bronconeumología. 35(9). 435–439. 8 indexed citations
14.
Sobradillo, V., Marc Miravitlles, R. Gabriel, et al.. (1999). Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo. Archivos de Bronconeumología. 35(4). 159–166. 153 indexed citations
15.
García‐Río, Francisco, et al.. (1997). Comparison of helium dilution and plethysmographic lung volumes in pregnant women. European Respiratory Journal. 10(10). 2371–2375. 17 indexed citations
16.
Lobato, Salvador Díaz, et al.. (1996). Programa de detección precoz de insuficiencia respiratoria en la enfermedad de Duchenne: resultados preliminares. Archivos de Bronconeumología. 32(6). 267–270. 1 indexed citations
17.
Álvarez-Sala, Rodolfo, et al.. (1995). Adaptación respiratoria durante el embarazo. Archivos de Bronconeumología. 31(4). 172–180. 1 indexed citations
18.
Alba, Davi F., et al.. (1994). [Asthma as the first manifestation of hepatic hydatidosis].. PubMed. 102(14). 556–7. 1 indexed citations
19.
Lobato, Salvador Díaz, et al.. (1994). [CT-guided fine-needle thoracic aspiration puncture. Its cost effectiveness and complications].. PubMed. 194(4). 265–9.
20.
Álvarez-Sala, Rodolfo, C. Villasante, Jesús Pino, & J. Villamor. (1986). Sleep apnea syndrome. Medicina Clínica. 86(4). 161–168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026